Sundström-Poromaa, Inger http://orcid.org/0000-0002-2491-2042
Comasco, Erika http://orcid.org/0000-0002-2174-2068
Funding for this research was provided by:
Uppsala University
Article History
Accepted: 11 April 2023
First Online: 12 May 2023
Declarations
:
: Open access funding provided by Uppsala University. The authors received funds from the SciLifeLab, the Swedish Research Council (2016-01439; 2020-01801; 2021-03089), the Swedish Society of Medicine (SLS-573171, SLS-597211, SLS-789101) and the Swedish Brain Foundation (2020-0255).
: ISP has served occasionally on advisory boards or acted as invited speaker at scientific meetings for Asarina Pharma, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, Sandoz, and Lundbeck A/S. EC has no conflict of interest to declare.
: Not applicable.
: Not applicable.
: ISP and EC contributed equally. All authors have read and approve the final version of the manuscript, and agree to be accountable for the work.
: Not applicable.
: Not applicable.
: Not applicable.